Zobrazeno 1 - 10
of 120
pro vyhledávání: '"J. M. Cardot"'
Autor:
J. M. Bohbot, J. M. Cardot
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2012 (2012)
The use of probiotics in the prevention or treatment of some vaginal infections has been the subject of numerous studies. To assess the presence of Lactobacillus casei rhamnosus (LCR35) in the vagina after an oral administration, an open randomised p
Externí odkaz:
https://doaj.org/article/dd897069355f4f78a6befe8e18a01863
Autor:
J. M. Cardot, P. Gauthier
Publikováno v:
FARMACIA. 69:238-245
Digitalization appears as a full mutation in the entire world, including health care. From applications (apps) to sensors, the digital is now fully integrated in daily life for patients. Monitoring treatments more easily and improving the design for
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J.-M. Cardot, Frédérique Respondek, A. Wagner, Annick Bernalier-Donadille, Michel Dapoigny, Claude Dubray, Anna Accarino, Fernando Azpiroz, Jordi Serra
Publikováno v:
Neurogastroenterology & Motility
Neurogastroenterology & Motility, 2017, 29 (2), pp.1-8. ⟨10.1111/nmo.12911⟩
Neurogastroenterology and Motility 2 (29), 1-8. (2017)
Neurogastroenterology & Motility, 2017, 29 (2), pp.1-8. ⟨10.1111/nmo.12911⟩
Neurogastroenterology and Motility 2 (29), 1-8. (2017)
Background: Short- chain fructooligosaccharides (scFOS) have beneficial effects in subjects with minor digestive complaints, but the potential mechanisms involved have not been elucidated. The aim of the study was to evaluate changes in rectal sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af70ace288f0645193950d8c45f305f
https://hal.archives-ouvertes.fr/hal-01658456/document
https://hal.archives-ouvertes.fr/hal-01658456/document
Autor:
G. Vergnault, David R. Owens, K. Kaiser, Tim Heise, A. Fischer, P. Ibarra, Karim Bagate, J.-M. Cardot, L. Nosek
Publikováno v:
Diabetes, Obesity and Metabolism. 14:1137-1144
Aims: In this randomized, single blind, cross-over study 2.5mg and 5mg of the modified-release terbutaline formulation (SKP-1052) were compared with conventional immediate-release terbutaline (IRT, 5mg) and placebo on overnight blood glucose (BG) and
Publikováno v:
The AAPS journal. 18(4)
The US-FDA recently posted a draft guideline for industry recommending procedures necessary to obtain a biowaiver for immediate-release oral dosage forms based on the Biopharmaceutics Classification System (BCS). This review compares the present FDA
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Dissolution Technologies. 14:15-19
Introduction Correlations between in vitro and in vivo data (IVIVC) are often used during pharmaceutical development in order to reduce development time and optimize the formulation. A good correlation is a tool for predicting in vivo results based o
Publikováno v:
British Journal of Clinical Pharmacology. 58:345-351
The aim of this study was to compare salivary miconazole pharmacokinetics following once daily application of bioadhesive tablets (50 or 100 mg), vs the current treatment with a gel (3 times a day, 375 mg day(-1)).A three way cross over study was car